Top news of the week: 22.12.2020.
Startups
A scene in hibernation
When the startup ecosystem comes out, perhaps next summer or fall, what will it be like, and will it produce the same level of activity and economic growth?
Westlake Village BioPartners Raises $500 Million for Biotech Venture Investments
Life-sciences venture firm Westlake Village BioPartners has raised $500 million across two new funds after quickly deploying its $327 million debut investment pool launched in 2018.
NVCA Member Spotlight: RiverVest
In our latest Member Spotlight, we spoke to three Managing Directors at St. Louis-based VC firm RiverVest about their firm and their portfolio.
Novartis acquires a small biotech and its trio of brain drugs
More active in neuroscience than most pharmaceutical firms, Novartis would gain three experimental drugs for depression, schizophrenia and movement disorders through the deal.
Not long ago, Moderna had plenty of doubters
A year ago, Moderna was not on anyone’s “Most Likely to Succeed” list. Then came the COVID-19 pandemic.
Research, Investment, Real Estate Development, and Job Growth Predictions Drive Greater Philadelphia’s Reputation as a Leading Cell & Gene Therapy Hub: 2020 In Review
PHILADELPHIA (December 17, 2020) – The Greater Philadelphia region’s reputation as a center for the cell and gene therapy and connected health industries grew in 2020, driven by ...
Looking Towards a Bright Future in an Uncertain World
As we look ahead to 2021, we continue to face a high-level of uncertainty about the pandemic and economic recovery, but there is a renewed sense of opportunity for our industry and ...
The payroll R&D credit, five years on
Yesterday, an FDA independent advisory panel voted to endorse Moderna’s COVID-19 vaccine, clearing the way for emergency use authorization as soon as today. Meanwhile, we’re taking a look ...